Liver disease is one of the biggest threats to public health, affecting as much as 5.5 million people worldwide. Mitochondrial dysfunction is associated with various acute and chronic liver diseases. Mitophagy, a selective form of autophagy for damaged/excessive mitochondria, plays a key role either in the pathogenesis or in maintaining hepatic homeostasis in response to various liver diseases.
Recent Advances:
Significant progress has been achieved to ascertain the causes of liver disease. The conserved pathways for mitochondrial degradation via mitophagy, the deregulation of mitophagy in liver diseases, and pharmacological or genetic maneuvers that alter the mitophagic flux for liver disease treatment have been widely studied but yet to be comprehensively reviewed.
Critical Issues:
Liver disease is considered a leading cause of mortality globally, causing the heavy burden of disability and the increased health care utilization that needs to be settled urgently. Mitophagy plays an important role in protecting liver from tissue damage to maintain hepatic homeostasis or in pathogenesis of liver disease. Elaborating mitophagy implicated in the pathogenesis of liver disease, as well as potential therapeutic regimens by targeting mitophagy is of great significance for the understanding and treatment of liver disease.
Future Directions:
This review comprehensively describes the distinct mitophagy signaling pathways and their interplay with various liver diseases. Given that mitophagy affects a wide array of physiological processes, a deeper understanding of how to modulate mitophagy could provide innovative avenues for precise therapy. Future studies based on pharmacologically or genetically targeting mitophagy-relevant factors will uncover the links between intact mitophagic responses and hepatic homeostasis in physiological and pathological settings. This will allow us to overcome obstacles of applying mitophagy as the therapeutic target in the clinic. Antioxid. Redox Signal. 38, 529–549.
Get full access to this article
View all access options for this article.
References
1.
AndrisaniOM. Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis. Viruses, 2013; 5(3):858–872; doi: 10.3390/v5030858
2.
AshrafiG, SchwarzTL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ, 2013; 20(1):31–42; doi: 10.1038/cdd.2012.81
3.
AxleyPD, RichardsonCT, SingalAK. Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease. Clin Liver Dis, 2019; 23(1):39–50; doi: 10.1016/j.cld.2018.09.011
4.
BalveyA, FernandezM. Translational control in liver disease. Front Physiol, 2021; 12:795298; doi: 10.3389/fphys.2021.795298
5.
BarbaroG, LorenzoGD, AstiA, et al.Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: Ultrastructural and biochemical findings. Am J Gastroenterol, 1999; 94(8):2198–2205; doi: 10.1111/j.1572-0241.1999.01294.x
6.
BauliesA, RibasV, NunezS, et al.Lysosomal cholesterol accumulation sensitizes to acetaminophen hepatotoxicity by impairing mitophagy. Sci Rep, 2015; 5:18017; doi: 10.1038/srep18017
7.
BenardG, RossignolR. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal, 2008; 10(8):1313–1342; doi: 10.1089/ars.2007.2000
8.
BhujabalZ, BirgisdottirAB, SjottemE, et al.FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. EMBO Rep, 2017; 18(6):947–961; doi: 10.15252/embr.201643147
9.
BishayeeA. The role of inflammation and liver cancer. Adv Exp Med Biol, 2014; 816:401–435; doi: 10.1007/978-3-0348-0837-8_16
10.
BlommeEAG. Toxicology strategies for drug discovery: Present and future. Chem Res Toxicol, 2016; 29(4):473–504; doi: 10.1021/acs.chemrestox.5b00407
11.
BouchardMJ, SchneiderRJ. The enigmatic X gene of hepatitis B virus. J Virol, 2004; 78(23):12725–12734; doi: 10.1128/JVI.78.23.12725-12734.2004
12.
CaiY, YangE, YaoX, et al.FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury. Redox Biol, 2021; 38:101792; doi: 10.1016/j.redox.2020.101792
13.
CaoX, XueY-J, DuJ-L, et al.Induction and suppression of innate antiviral responses by hepatitis A virus. Front Microbiol, 2018; 9:1865; doi: 10.3389/fmicb.2018.01865
ChangJY, YiH-S, KimH-W, et al.Dysregulation of mitophagy in carcinogenesis and tumor progression. Biochim Biophys Acta Bioenerg, 2017; 1858(8):633–640; doi: 10.1016/j.bbabio.2016.12.008
16.
ChaoX, DingW-X. Role and mechanisms of autophagy in alcohol-induced liver injury. Adv Pharmacol, 2019; 85:109–131; doi: 10.1016/bs.apha.2019.01.008
17.
ChaoX, WangH, JaeschkeH, et al.Role and mechanisms of autophagy in acetaminophen-induced liver injury. Liver Int, 2018; 38(8):1363–1374; doi: 10.1111/liv.13866
18.
ChenG, HanZ, FengD, et al.A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell, 2014; 54(3):362–377; doi: 10.1016/j.molcel.2014.02.034
19.
ChenH-N, ChenY, ZhouZ-G, et al.A novel role for ketoconazole in hepatocellular carcinoma treatment: Linking PTGS2 to mitophagy machinery. Autophagy, 2019a;15(4):733–734; doi: 10.1080/15548627.2019.1569934
20.
ChenJ, BaiM, NingC, et al.Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/Akt/Hif-1α/Cyclin D1 pathway. Oncogene, 2016; 35(19):2506–2517; doi: 10.1038/onc.2015.316
21.
ChenL-Y, YangB, ZhouL, et al.Promotion of mitochondrial energy metabolism during hepatocyte apoptosis in a rat model of acute liver failure. Mol Med Rep, 2015; 12(4):5035–5041; doi: 10.3892/mmr.2015.4029
22.
ChenM, DuD, ZhengW, et al.Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: A potential mechanism by which hepatitis D virus downregulates glutathione S-transferase P1 and induces liver injury and hepatocarcinogenesis. Biochem Cell Biol, 2019b;97(2):130–139; doi: 10.1139/bcb-2017-0321
23.
ChenY, ChenHN, WangK, et al.Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma. J Hepatol, 2019c;70(1):66–77; doi: 10.1016/j.jhep.2018.09.022
24.
ChenY, ParkHJ, ParkJ, et al.Carbon monoxide ameliorates acetaminophen-induced liver injury by increasing hepatic HO-1 and Parkin expression. FASEB J, 2019d;33(12):13905–13919; doi: 10.1096/fj.201901258RR
25.
ChenYY, WangWH, CheL, et al.BNIP3L-dependent mitophagy promotes HBx-induced cancer stemness of hepatocellular carcinoma cells via glycolysis metabolism reprogramming. Cancers (Basel), 2020; 12(3):655; doi: 10.3390/cancers12030655
26.
ChengD, ZhangL, YangG, et al.Hepatitis C virus NS5A Drives a PTEN-PI3K/Akt feedback loop to support cell survival. Liver Int, 2015; 35(6):1682–1691; doi: 10.1111/liv.12733
27.
ChengD, ZhaoL, ZhangL, et al.P53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45a expression via the NF-κB and PI3K–Akt Pathways. J Gen Virol, 2013; 94(Pt 2):326–335; doi: 10.1099/vir.0.046052-0
28.
ChiHC, ChenSL, LinSL, et al.Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover. Oncogene, 2017; 36(37):5274–5284; doi: 10.1038/onc.2017.136
29.
ChoiGE, LeeHJ, ChaeCW, et al.BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat Commun, 2021; 12(1):487; doi: 10.1038/s41467-020-20679-y
30.
ChuJYK, OuJ-HJ. Autophagy in HCV replication and protein trafficking. Int J Mol Sci, 2021; 22(3):1089; doi: 10.3390/ijms22031089
31.
Cortez-PintoH, ChathamJ, ChackoVP, et al.Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study. JAMA, 1999; 282(17):1659–1664; doi: 10.1001/jama.282.17.1659
32.
DingW-X, LiM, YinX-M. Selective taste of ethanol-induced autophagy for mitochondria and lipid droplets. Autophagy, 2011; 7(2):248–249; doi: 10.4161/auto.7.2.14347.
33.
DoskeyCM, BuranasudjaV, WagnerBA, et al.Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy. Redox Biol, 2016; 10:274–284; doi: 10.1016/j.redox.2016.10.010
34.
DuH, YangJ, BaiJ, et al.A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type 1. PLoS One, 2017; 12(4):e0175495.; doi: 10.1371/journal.pone.0175495
35.
DusheikoGM. Treatment and prevention of chronic viral hepatitis. Pharmacol Ther, 1995; 65(1):47–73; doi: 10.1016/0163-7258(94)00056-9
36.
EidN, ItoY, HoribeA, et al.Ethanol-induced mitophagy in liver is associated with activation of the Pink1-Parkin pathway triggered by oxidative DNA damage. Histol Histopathol, 2016; 31(10):1143–1159; doi: 10.14670/HH-11-747
37.
El-DeranyMO, El-DemerdashE. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/beta-catenin signaling crosstalk. Biochem Pharmacol, 2020; 177:113942; doi: 10.1016/j.bcp.2020.113942
38.
FatimaK, MathewS, SuhailM, et al.Docking studies of Pakistani HCV NS3 helicase: A possible antiviral drug target. PLoS One, 2014; 9(9):e106339; doi: 10.1371/journal.pone.0106339
39.
FengH, SanderA-L, Moreira-SotoA, et al.Hepatovirus 3ABC proteases and evolution of mitochondrial antiviral signaling protein (MAVS). J Hepatol, 2019; 71(1):25–34; doi: 10.1016/j.jhep.2019.02.020
40.
FierroNA, RealpeM, Meraz-MedinaT, et al.Hepatitis E virus: An ancient hidden enemy in Latin America. World J Gastroenterol, 2016; 22(7):2271–2283; doi: 10.3748/wjg.v22.i7.2271
41.
FisicaroP, BariliV, MontaniniB, et al.Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat Med, 2017; 23(3):327–336; doi: 10.1038/nm.4275
42.
GaoB, BatallerR. Alcoholic liver disease: Pathogenesis and new therapeutic targets. Gastroenterology, 2011; 141(5):1572–1585; doi: 10.1053/j.gastro.2011.09.002
GlickD, ZhangW, BeatonM, et al.BNip3 regulates mitochondrial function and lipid metabolism in the liver. Mol Cell Biol, 2012; 32(13):2570–2584.; doi: 10.1128/MCB.00167-12
45.
GongLL, YangS, ZhangW, et al.Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. J Pharmacol Sci, 2018; 136(4):189–195; doi: 10.1016/j.jphs.2017.11.007
46.
GregorieffA, WranaJL. Hippo signalling in intestinal regeneration and cancer. Curr Opin Cell Biol, 2017; 48:17–25; doi: 10.1016/j.ceb.2017.04.005
47.
HangW, ShuH, WenZ, et al.N-acetyl cysteine ameliorates high-fat diet-induced nonalcoholic fatty liver disease and intracellular triglyceride accumulation by preserving mitochondrial function. Front Pharmacol, 2021; 12:636204; doi: 10.3389/fphar.2021.636204
48.
HauptK, JahreisG, LinnertM, et al.The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop. J Biol Chem, 2012; 287(23):19665–19673; doi: 10.1074/jbc.M111.317214
49.
HinoK, NishinaS, SasakiK, et al.Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection. Free Radic Biol Med, 2019; 133:193–199; doi: 10.1016/j.freeradbiomed.2018.09.044
50.
HuangXY, LiD, ChenZX, et al.Hepatitis B virus X protein elevates Parkin-mediated mitophagy through Lon Peptidase in starvation. Exp Cell Res, 2018; 368(1):75–83; doi: 10.1016/j.yexcr.2018.04.016
51.
InnokentevA, KankiT. Mitophagy in yeast: Molecular mechanism and regulation. Cells, 2021; 10(12):3569; doi: 10.3390/cells10123569
52.
IsaevaOV, Il'chenkoLY, SaryglarAA, et al.Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region. Vopr Virusol, 2021; 66(1):74–83; doi: 10.36233/0507-4088-29
53.
IshiiI, HaradaY, KasaharaT. Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration. Front Oncol, 2012; 2:137; doi: 10.3389/fonc.2012.00137
54.
JasseyA, LiuCH, ChangouCA, et al.Hepatitis C virus non-structural protein 5A (NS5A) disrupts mitochondrial dynamics and induces mitophagy. Cells, 2019; 8(4):290; doi: 10.3390/cells8040290
55.
JeeA, SernoskieSC, UetrechtJ. Idiosyncratic drug-induced liver injury: Mechanistic and clinical challenges. Int J Mol Sci, 2021; 22(6):2954.; doi: 10.3390/ijms22062954
KangSW, HaydarG, TanianeC, et al.AMPK activation prevents and reverses drug-induced mitochondrial and hepatocyte injury by promoting mitochondrial fusion and function. PLoS One, 2016; 11(10):e0165638; doi: 10.1371/journal.pone.0165638
58.
KePY. Mitophagy in the pathogenesis of liver diseases. Cells, 2020; 9(4):831; doi: 10.3390/cells9040831
59.
KhambuB, WangL, ZhangH, et al.The activation and function of autophagy in alcoholic liver disease. Curr Mol Pharmacol, 2017; 10(3):165–171; doi: 10.2174/1874467208666150817112654
60.
KimH-B, KimM, ParkY-S, et al.Prostaglandin E2 activates Yap and a positive-signaling loop to promote colon regeneration following colitis but also carcinogenesis in mice. Gastroenterology, 2017a;152(3):616–630; doi: 10.1053/j.gastro.2016.11.005
61.
KimSJ, JangJY, KimEJ, et al.Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation. Hepatology, 2017b;66(3):758–771; doi: 10.1002/hep.29177
62.
KimSJ, KhanM, QuanJ, et al.Hepatitis B virus disrupts mitochondrial dynamics: Induces fission and mitophagy to attenuate apoptosis. PLoS Pathog, 2013a;9(12):e1003722; doi: 10.1371/journal.ppat.1003722
63.
KimSJ, SyedGH, SiddiquiA. Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog, 2013b;9(3):e1003285; doi: 10.1371/journal.ppat.1003285
64.
KimaS-J, SyedaGH, KhanaM, et al.Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A, 2014; 111(17):6413–6418; doi: 10.1073/pnas.1321114111
65.
KitaseA, HinoK, FurutaniT, et al.In situ detection of oxidized N-3 polyunsaturated fatty acids in chronic hepatitis C: Correlation with hepatic steatosis. J Gastroenterol, 2005; 40(6):617–624; doi: 10.1007/s00535-005-1596-x
66.
KomissarovAA, KarasevaMA, RoschinaMP, et al.Individual expression of hepatitis A virus 3C protease induces ferroptosis in human cells in vitro. Int J Mol Sci, 2021; 22(15):7906; doi: 10.3390/ijms22157906
67.
KonK, KimJ-S, JaeschkeH, et al.Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology, 2004; 40(5):1170–1179; doi: 10.1002/hep.20437
68.
KorenagaM, WangT, LiY, et al.Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem, 2005; 280(45):37481–37488; doi: 10.1074/jbc.M506412200
69.
KuangY, MaK, ZhouC, et al.Structural basis for the phosphorylation of FUNDC1 LIR as a molecular switch of mitophagy. Autophagy, 2016; 12(12):2363–2373; doi: 10.1080/15548627.2016.1238552
70.
KumarS, DuanQ, WuR, et al.Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev, 2021; 176:113869; doi: 10.1016/j.addr.2021.113869
71.
LaiY, ZengN, WangM, et al.The VP3 protein of duck hepatitis A virus mediates host cell adsorption and apoptosis. Sci Rep, 2019; 9(1):16783; doi: 10.1038/s41598-019-53285-0
72.
LaniniS, UstianowskiA, PisapiaR, et al.Viral hepatitis etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am, 2019; 33(4):1045–1062; doi: 10.1016/j.idc.2019.08.004
73.
LazarouM, JinSM, KaneLA, et al.Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell, 2012; 22(2):320–333; doi: 10.1016/j.devcel.2011.12.014
74.
LazarouM, SliterDA, KaneLA, et al.The ubiquitin kinase Pink1 recruits autophagy receptors to induce mitophagy. Nature, 2015; 524(7565):309–314; doi: 10.1038/nature14893
75.
LeeDH, JungYY, ParkMH, et al.Peroxiredoxin 6 confers protection against nonalcoholic fatty liver disease through maintaining mitochondrial function. Antioxid Redox Signal, 2019a;31(5):387–402; doi: 10.1089/ars.2018.7544
76.
LeeJ, ParkJ-S, RohYS. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm Res, 2019b;42(11):935–946; doi: 10.1007/s12272-019-01178-1
77.
LeeK, HaddadA, OsmeA, et al.Hepatic mitochondrial defects in a nonalcoholic fatty liver disease mouse model are associated with increased degradation of oxidative phosphorylation subunits. Mol Cell Proteomics, 2018; 17(12):2371–2386; doi: 10.1074/mcp.RA118.000961
78.
LhommeS, MarionO, AbravanelF, et al.Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J Clin Med, 2020; 9(2):331; doi: 10.3390/jcm9020331
79.
LiG, LiJ, ShaoR, et al.FUNDC1: A promising mitophagy regulator at the mitochondria-associated membrane for cardiovascular diseases. Front Cell Dev Biol, 2021; 16(9):788634; doi: 10.3389/fcell.2021.788634
80.
LiM, JiaJ, ZhangX, et al.Selective binding of mitophagy receptor protein Bcl-rambo to LC3/GABARAP family proteins. Biochem Biophys Res Commun, 2020a;530(1):292–300; doi: 10.1016/j.bbrc.2020.07.039
81.
LiM, ShaoJ, GuoZ, et al.Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC. J Cell Mol Med, 2020b;24(5):3091–3107; doi: 10.1111/jcmm.14971
82.
LiP, LiY, WangY, et al.Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids. Sci Adv, 2022a;8(3):eabj5908; doi: 10.1126/sciadv.abj5908
83.
LiR, XinT, LiD, et al.Therapeutic effect of sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. Redox Biol, 2018; 18:229–243; doi: 10.1016/j.redox.2018.07.011
84.
LiW, LiY, SirajS, et al.FUN14 domain-containing 1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. Hepatology, 2019; 69(2):604–621; doi: 10.1002/hep.30191
85.
LiX, ShaoS, LiH, et al.Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice. J Cell Mol Med, 2020c;24(15):8623–8635; doi: 10.1111/jcmm.15493
86.
LiX, ShiZ, ZhuY, et al.Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting Pink1-mediated mitophagy in mice. Br J Pharmacol, 2020d;177(15):3591–3607; doi: 10.1111/bph.15083
87.
LiY, YuP, KesslerAL, et al.Hepatitis E virus infection activates NLRP3 inflammasome antagonizing interferon response but therapeutically targetable. Hepatology, 2022b;75(1):196–212; doi: 10.1002/hep.32114
88.
LinD, HeH, JiH, et al.Wolfberries potentiate mitophagy and enhance mitochondrial biogenesis leading to prevention of hepatic steatosis in obese mice: The role of AMP-activated protein kinase Α2 subunit. Mol Nutr Food Res, 2014; 58(5):1005–1015; doi: 10.1002/mnfr.201300186
89.
LinMT, BealMF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006; 443(7113):787–795; doi: 10.1038/nature05292
90.
LindenMA, LopezKT, FletcherJA, et al.Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats. Appl Physiol Nutr Metab, 2015; 40(10):1038–1047; doi: 10.1139/apnm-2015-0236
LiuT, YuH, ZhangZ, et al.Intestinal ELF4 deletion exacerbates alcoholic liver disease by disrupting gut homeostasis. Int J Mol Sci, 2022; 23(9):4825; doi: 10.3390/ijms23094825
93.
LouvetA, MathurinP. Alcoholic liver disease: Mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol, 2015; 12(4):231–242; doi: 10.1038/nrgastro.2015.35
94.
LuX, XuanW, LiJ, et al.AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy. Autophagy, 2021; 17(11):3622–3643; doi: 10.1080/15548627.2021.1886829
95.
MansouriA, GattolliatC-H, AsselahT. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology, 2018; 155(3):629–647.; doi: 10.1053/j.gastro.2018.06.083
96.
McGillMR, JaeschkeH. Metabolism and disposition of acetaminophen: Recent advances in relation to hepatotoxicity and diagnosis. Pharm Res, 2013; 30(9):2174–2187; doi: 10.1007/s11095-013-1007-6
97.
MilosMihajlovic, VinkenM. Mitochondria as the target of hepatotoxicity and drug-induced liver injury: Molecular mechanisms and detection methods. Int J Mol Sci, 2022; 23(6):3315; doi: 10.3390/ijms23063315
MurakawaT, YamaguchiO, HashimotoA, et al.Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat Commun, 2015; 6:7527; doi: 10.1038/ncomms8527
100.
NairS, ChackoVP, ArnoldC, et al.Hepatic ATP reserve and efficiency of replenishing: Comparison between obese and nonobese normal individuals. Am J Gastroenterol, 2003; 98(2):466–470; doi: 10.1016/S0002-9270(02)05889-6
101.
NakahiraK, HaspelJA, RathinamVA, et al.Autophagy proteins regulate innate immune response by inhibiting NALP3 inflammasome-mediated mitochondrial DNA release. Nat Immunol, 2011; 12(3):222–230; doi: 10.1038/ni.1980
NickelA, KohlhaasM, MaackC. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol, 2014; 73:26–33; doi: 10.1016/j.yjmcc.2014.03.011
104.
OnishiM, YamanoK, SatoM, et al.Molecular mechanisms and physiological functions of mitophagy. EMBO J, 2021; 40(3):e104705.; doi: 10.15252/embj.2020104705
105.
PangL, LiuK, LiuD, et al.Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell Death Dis, 2018; 9(2):90–102; doi: 10.1038/s41419-017-0136-y
106.
Perez-CarrerasM, Del HoyoP, MartinMA, et al.Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology, 2003; 38(4):999–1007; doi: 10.1053/jhep.2003.50398
107.
PooleLP, MacleodKF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci, 2021; 78(8):3817–3851; doi: 10.1007/s00018-021-03774-1
108.
Prieto-DomínguezN, Méndez-BlancoC, FondevilaF, et al.Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy. Oncotarget, 2017; 8(53):91402–91414; doi: 10.18632/oncotarget.20592
109.
QianH, ChaoX, DingWX. A Pink1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?. Autophagy, 2018; 14(4):563–566; doi: 10.1080/15548627.2018.1425057
110.
QuC, ZhangS, WangW, et al.Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target. FASEB J, 2019; 33(1):1008–1019; doi: 10.1096/fj.201800620R
111.
QuanY, XinY, TianG, et al.Mitochondrial ROS-modulated mtDNA: A potential target for cardiac aging. Oxid Med Cell Longev, 2020; 2020:9423593; doi: 10.1155/2020/9423593
112.
RahmaniZ, HuhKW, LasherR, et al.Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol, 2000; 74(6):2840–2846; doi: 10.1128/jvi.74.6.2840-2846.2000
113.
RamachandranA, JaeschkeH. Acetaminophen toxicity: Novel insights into mechanisms and future perspectives. Gene Expr, 2018; 18(1):19–30; doi: 10.3727/105221617X15084371374138
114.
RamachandranA, LebofskyM, BainesCP, et al.Cyclophilin D deficiency protects against acetaminopheninduced oxidant stress and liver injury. Free Radic Res, 2011; 45(2):156–164; doi: 10.3109/10715762.2010.520319
115.
RizzettoM. Hepatitis D virus: Introduction and epidemiology. Cold Spring Harb Perspect Med, 2015; 5(7):a021576; doi: 10.1101/cshperspect.a021576
116.
RuggieriV, MazzoccoliC, PazienzaV, et al.Hepatitis C virus, mitochondria and auto/mitophagy: Exploiting a host defense mechanism. World J Gastroenterol, 2014; 20(10):2624–2633; doi: 10.3748/wjg.v20.i10.2624
117.
RuiYN, XuZ, PatelB, et al.Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol, 2015; 17(3):262–275; doi: 10.1038/ncb3101
118.
SayinerM, KoenigA, HenryL, et al.Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis, 2016; 20(2):205–214.; doi: 10.1016/j.cld.2015.10.001
119.
ScheelTKH, RiceCM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med, 2013; 19(7):837–849; doi: 10.1038/nm.3248
SekineS, YouleRJ. Pink1 import regulation; a fine system to convey mitochondrial stress to the cytosol. BMC Biol, 2018; 16(1):2; doi: 10.1186/s12915-017-0470-7
ShanaS, ShenZ, ZhangC, et al.Mitophagy protects against acetaminophen-induced acute liver injury in mice through inhibiting NLRP3 inflammasome activation. Biochem Pharmacol, 2019; 169:113643; doi: 10.1016/j.bcp.2019.113643
124.
ShaoN, KuangHY, HaoM, et al.Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. Diabetes Metab Res Rev, 2014; 30(6):521–529; doi: 10.1002/dmrr.256110.1002/dmrr
125.
ShaoN, YuXY, MaXF, et al.Exenatide delays the progression of nonalcoholic fatty liver disease in C57BL/6 mice, which may involve inhibition of the NLRP3 inflammasome through the mitophagy pathway. Gastroenterol Res Pract, 2018; 2018:1864307; doi: 10.1155/2018/1864307
126.
ShengJ, ShenL, SunL, et al.Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial-lysosomal crosstalk. Cell Prolif, 2019; 52(3):e12609; doi: 10.1111/cpr.12609
127.
ShiC, CaiY, LiY, et al.Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways. Redox Biol, 2018; 14:59–71; doi: 10.1016/j.redox.2017.08.013
128.
SiaD, VillanuevaA, FriedmanSL, et al.Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology, 2017; 152(4):745–761; doi: 10.1053/j.gastro.2016.11.048
129.
SimõesaICM, FontesbA, PintoncP, et al.Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol, 2018; 95:93–99; doi: 10.1016/j.biocel.2017.12.019
130.
SimulaMP, ReVD. Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: A focus on recent advances in proteomics. Proteomics Clin Appl, 2010; 4(10-11):782–793; doi: 10.1002/prca.201000049
131.
SiuGKY, ZhouF, YuMK, et al.Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation. Sci Rep, 2016; 6:23464.; doi: 10.1038/srep23464
132.
SmithDB, SimmondsP, JameelS, et al.Consensus proposals for classification of the family Hepeviridae. J Gen Virol, 2015; 96:1191–1192; doi: 10.1099/vir.0.068429-0
133.
StockdaleAJ, KreuelsB, HenrionMYR, et al.The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol, 2020; 73(3):523–532; doi: 10.1016/j.jhep.2020.04.008
134.
SuL, WangR, QiuT, et al.The protective effect of baicalin on duck hepatitis A virus type 1-induced duck hepatic mitochondria dysfunction by activating nuclear erythroid 2-related factor 2/antioxidant responsive element signaling pathway. Poult Sci, 2021; 100(5):101032; doi: 10.1016/j.psj.2021.101032
135.
Suarez-AmaranL, UsaiC, Di ScalaM, et al.A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction. J Hepatol, 2017; 67(4):669–679; doi: 10.1016/j.jhep.2017.05.010
136.
TangY, GaoC, XingM, et al.Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage. Food Chem Toxicol, 2012; 50(5):1194–1200; doi: 10.1016/j.fct.2012.02.008
137.
ThuPNT, QuynhMNT, VanLP, et al.Determination of risk factors associated with the failure of 12 weeks of direct-acting antiviral therapy in patients with hepatitis C: A prospective study. Biomed Res Int, 2022; 6054677; doi: 10.1155/2022/6054677
138.
TsutsumiT, MatsudaM, AizakiH, et al.Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon, prohibitin, in cells expressing hepatitis C virus core protein. Hepatology, 2009; 50(2):378–386; doi: 10.1002/hep.22998
139.
UsaiC, MaestroS, CampsG, et al.TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection. JHEP Rep, 2020; 2(3):100098; doi: 10.1016/j.jhepr.2020.100098
WangC, MaC, GongL, et al.Macrophage polarization and its role in liver disease. Front Immunol, 2021a;12:803037; doi: 10.3389/fimmu.2021.803037
142.
WangH, NiH-M, ChaoX, et al.Double deletion of Pink1 and Parkin impairs hepatic mitophagy and exacerbates acetaminophen-induced liver injury in mice. Redox Biol, 2019a;22:101148; doi: 10.1016/j.redox.2019.101148
143.
WangH, ZhengY, HuangJ, et al.Mitophagy in antiviral immunity. Front Cell Dev Biol, 2021b;9:723108; doi: 10.3389/fcell.2021.723108
144.
WangL, LiuX, NieJ, et al.ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology, 2015; 61(2):486–496; doi: 10.1002/hep.27420
145.
WangT, WeinmanSA. Interactions between hepatitis C virus and mitochondria: Impact on pathogenesis and innate immunity. Curr Pathobiol Rep, 2013; 1(3):179–187; doi: 10.1007/s40139-013-0024-9
146.
WangY, MetselaarHJ, PeppelenboschMP, et al.Chronic hepatitis E in solid-organ transplantation: The key implications of immunosuppressants. Curr Opin Infect Dis, 2014; 27(4):303–308; doi: 10.1097/QCO.0000000000000074
WangY, WangZ, SunJ, et al.Identification of HCC subtypes with different prognosis and metabolic patterns based on mitophagy. Front Cell Dev Biol, 2021c;16(9):799507; doi: 10.3389/fcell.2021.799507
149.
WangZ, DaiZ, LuoZ, et al.Identification of pyrvinium, an anthelmintic drug, as a novel anti-adipogenic compound based on the gene expression microarray and connectivity map. Molecules, 2019b;24(13):2391; doi: 10.3390/molecules24132391
150.
WebbGW, DaltonHR. Hepatitis E. An underestimated emerging threat. Ther Adv Infectious Dis, 2019; 6:1–18; doi: 10.1177/2049936119837162
151.
WeiC-W, ZhouT-A, DzhagalovIL, et al.Multicolor flow cytometry-based quantification of mitochondria and lysosomes in T cells. J Vis Exp, 2019; 9(143):e58844; doi: 10.3791/58844
152.
WeilZM, CorriganbJD, KarelinaaK. Alcohol abuse after traumatic brain injury: Experimental and clinical evidence. Neurosci Biobehav Rev, 2016; 62:89–99; doi: 10.1016/j.neubiorev.2016.01.005
153.
WilliamsJA, DingW-X. A mechanistic review of mitophagy and its role in protection against alcoholic liver disease. Biomolecules, 2015; 5(4):2619–2642; doi: 10.3390/biom5042619
154.
WilliamsJA, DingWX. Mechanisms, pathophysiological roles and methods for analyzing mitophagy—Recent insights. Biol Chem, 2018; 399(2):147–178; doi: 10.1515/hsz-2017-0228
155.
WilliamsJA, NiH-M, DingY, et al.Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice. Am J Physiol Gastrointest Liver Physiol, 2015a;309(5):G324–G340; doi: 10.1152/ajpgi.00108.2015
156.
WilliamsJA, NiHM, HaynesA, et al.Chronic deletion and acute knockdown of Parkin have differential responses to acetaminophen-induced mitophagy and liver injury in mice. J Biol Chem, 2015b;290(17):10934–10946; doi: 10.1074/jbc.M114.602284
157.
WilsonGK, TennantDA, McKeatingJA. Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions. J Hepatol, 2014; 61(6):1397–1406; doi: 10.1016/j.jhep.2014.08.025
158.
World Health Organization. Global Status Report on Alcohol and Health 2018. World Health Organization: Geneva; 2018.
159.
WuH, WangT, LiuY, et al.Mitophagy promotes sorafenib resistance through hypoxia-inducible atad3a dependent axis. J Exp Clin Cancer Res, 2020; 39(1):274; doi: 10.1186/s13046-020-01768-8
160.
XiongW, WangR, MaoW, et al.Icariin and its phosphorylated derivatives reduce duck hepatitis A virus serotype 1-induced oxidative stress and inflammatory damage in duck embryonic hepatocytes through mitochondrial regulation. Res Vet Sci, 2021; 139:133–139; doi: 10.1016/j.rvsc.2021.07.014
161.
XuY, ShenJ, RanZ. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy, 2020; 16(1):3–17; doi: 10.1080/15548627.2019.1603547
162.
YamadaT, MurataD, AdachiY, et al.Mitochondrial stasis reveals P62-mediated ubiquitination in Parkin-independent mitophagy and mitigates nonalcoholic fatty liver disease. Cell Metab, 2018; 28(4):588.e5–604.e5; doi: 10.1016/j.cmet.2018.06.014
163.
YamanoK, YouleRJ. Pink1 is degraded through the N-end rule pathway. Autophagy, 2013; 9(11):1758–1769; doi: 10.4161/auto.24633
164.
YangY, LiangY, QuL, et al.Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A, 2007; 104(17):7253–7258; doi: 10.1073/pnas.0611506104
165.
YangY, ShiR, SheR, et al.Effect of swine hepatitis E virus on the livers of experimentally infected Mongolian gerbils by swine hepatitis E virus. Virus Res, 2015; 208:171–179; doi: 10.1016/j.virusres.2015.06.007
166.
YangY, TianJ, ZhangH, et al.Mitochondrial dysfunction and mitophagy pathway activation in hepatitis E virus-infected livers of Mongolian gerbils. Virus Res, 2021; 302:198369; doi: 10.1016/j.virusres.2021.198369
167.
YaoJ, WangJ, XuY, et al.CDK9 inhibition blocks the initiation of PINK1-PRKN mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma. Autophagy, 2022; 18(8):1879–1897; doi: 10.1080/15548627.2021.2007027
168.
YeH, NelsonLJ, MoralMGD, et al.Dissecting the molecular pathophysiology of drug-induced liver injury. World J Gastroenterol, 2018; 24(13):1373–1385; doi: 10.3748/wjg.v24.i13.1373
169.
YinX, LiX, AmbardekarC, et al.Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog, 2017; 13(5):e1006417; doi: 10.1371/journal.ppat.1006417
170.
YooS-M, JungY-K. A molecular approach to mitophagy and mitochondrial dynamics. Mol Cells, 2018; 41(1):18–26; doi: 10.14348/molcells.2018.2277
171.
YooYS, ParkYJ, LeeHS, et al.Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B virus X protein aggregates in the liver pathogenesis. Cell Death Dis, 2019; 10(12):938; doi: 10.1038/s41419-019-2175-z
172.
YuX, HaoM, LiuY, et al.Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol, 2019; 864:172715; doi: 10.1016/j.ejphar.2019.172715
173.
YuX, XuY, ZhangS, et al.Quercetin attenuates chronic ethanol-induced hepatic mitochondrial damage through enhanced mitophagy. Nutrients, 2016; 8(1):27; doi: 10.3390/nu8010027
174.
ZhangJ, NeyP. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ, 2009; 16(7):939–946; doi: 10.1038/cdd.2009.16
175.
ZhangP, ChenS, TangH, et al.CoQ10 protects against acetaminophen-induced liver injury by enhancing mitophagy. Toxicol Appl Pharmacol, 2021; 410:115355; doi: 10.1016/j.taap.2020.115355
176.
ZhangR, ChuK, ZhaoN, et al.Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL/6 mice by ameliorating oxidative stress and restoring autophagic flux. Front Pharmacol, 2019a;10:1693; doi: 10.3389/fphar.2019.01693
177.
ZhangS, WangY, CaoY, et al.Inhibition of the Pink1-Parkin pathway enhances the lethality of sorafenib and regorafenib in hepatocellular carcinoma. Front Pharmacol, 2022; 13:851832; doi: 10.3389/fphar.2022.851832
178.
ZhangT, XueL, TangC, et al.BNIP3 protein suppresses PINK1 kinase proteolytic cleavage to promote mitophagy. J Biol Chem, 2016; 291(41):21616–21629; doi: 10.1074/jbc.M116.733410
179.
ZhangY, LiuD, HuH, et al.HIF-1alpha/BNIP3 signaling pathway-induced-autophagy plays protective role during myocardial ischemia-reperfusion injury. Biomed Pharmacother, 2019b;120:109464; doi: 10.1016/j.biopha.2019.109464
180.
ZhaoH, LiuS, ZhaoH, et al.Protective effects of fucoidan against ethanol-induced liver injury through maintaining mitochondrial function and mitophagy balance in rats. Food Funct, 2021a;12(9):3842–3854; doi: 10.1039/d0fo03220d
181.
ZhaoY, ZhouL, LiH, et al.Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the mitophagy pathway. Mol Ther Nucleic Acids, 2021b;23:264–276; doi: 10.1016/j.omtn.2020.09.040
182.
ZhengY, HuangC, LuL, et al.STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib. J Hematol Oncol, 2021; 14(1):16; doi: 10.1186/s13045-020-01029-3
183.
ZhongZ, LemastersJJ. A unifying hypothesis linking hepatic adaptations for ethanol metabolism to the proinflammatory and profibrotic events of alcoholic liver disease. Alcohol Clin Exp Res, 2018; 42(11):2072–2089; doi: 10.1111/acer.13877
184.
ZhongZ, RamsheshVK, RehmanH, et al.Acute ethanol causes hepatic mitochondrial depolarization in mice: role of ethanol metabolism. PLoS One, 2014; 9(3):e91308; doi: 10.1371/journal.pone.0091308
185.
ZhouH, DuW, LiY, et al.Effects of melatonin on fatty liver disease: The role of NR4A1/DNA-PKcs/p53 pathway, mitochondrial fission, and mitophagy. J Pineal Res, 2018; 64(1):e12450; doi: 10.1111/jpi.12450
186.
ZhouH, ZhuP, WangJ, et al.DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy. Signal Transduct Target Ther, 2019a;4:56; doi: 10.1038/s41392-019-0094-1
187.
ZhouT, ChangL, LuoY, et al.Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol, 2019b;21:101120; doi: 10.1016/j.redox.2019.101120
